Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Agnieszka Kłosowska-Wardęga"'
Autor:
Agnieszka Kłosowska-Wardega, Yoko Hasumi, Mikhail Burmakin, Aive Ahgren, Linda Stuhr, Ingrid Moen, Rolf K Reed, Kristofer Rubin, Carina Hellberg, Carl-Henrik Heldin
Publikováno v:
PLoS ONE, Vol 4, Iss 12, p e8149 (2009)
Elevation of the interstitial fluid pressure (IFP) of carcinoma is an obstacle in treatment of tumors by chemotherapy and correlates with poor drug uptake. Previous studies have shown that treatment with inhibitors of platelet-derived growth factor (
Externí odkaz:
https://doaj.org/article/59cdccc99380471090cc1e6d18009326
Autor:
Aleksandra Jurek, Agnieszka Kłosowska-Wardęga, Piotr Wardega, Haisha Ma, David Mazaud, Carl-Henrik Heldin, Johan Lennartsson, Ulla Engström
Publikováno v:
Cellular signalling. 27(11)
Histidine domain-containing protein tyrosine phosphatase (HD-PTP) is a putative phosphatase that has been shown to affect the signaling and downregulation of certain receptor tyrosine kinases. To investigate if HD-PTP affects platelet-derived growth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b85b2854c2fdd3accdb563fb506db05
https://pubmed.ncbi.nlm.nih.gov/26232618
https://pubmed.ncbi.nlm.nih.gov/26232618
Publikováno v:
Melanoma research. 21(1)
Melanomas respond poorly to chemotherapy. In this study, we investigated the sensitization of B16 mouse melanoma tumors to paclitaxel by a combination of two tyrosine kinase inhibitors: vatalanib, targeting vascular endothelial growth factor receptor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6ff7637276ffc439fb9a1fd34788fb8
https://pubmed.ncbi.nlm.nih.gov/20975605
https://pubmed.ncbi.nlm.nih.gov/20975605
Autor:
Carl-Henrik Heldin, Carina Hellberg, Yoko Hasumi, Arne Östman, Masao Furuhashi, Agnieszka Kłosowska-Wardęga
Publikováno v:
International journal of cancer. 121(12)
The aim of our study was to further explore the use of anti-angiogenic therapy targeting the vascular endothelial growth factor receptor (VEGFR) on endothelial cells while simultaneously targeting platelet-derived growth factor receptors (PDGFRs) on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2773acd12d5f83e45bf7357648c9ca20
https://pubmed.ncbi.nlm.nih.gov/17691110
https://pubmed.ncbi.nlm.nih.gov/17691110
Autor:
Carina Hellberg, Agnieszka Kłosowska-Wardęga, Rolf K. Reed, Yoko Hasumi, Aive Åhgren, Linda Elin Birkhaug Stuhr, Kristofer Rubin, Ingrid Moen, Carl-Henrik Heldin, Mikhail Burmakin
Publikováno v:
PLoS ONE
PLoS ONE, Vol 4, Iss 12, p e8149 (2009)
PLoS ONE, Vol 4, Iss 12, p e8149 (2009)
Elevation of the interstitial fluid pressure (IFP) of carcinoma is an obstacle in treatment of tumors by chemotherapy and correlates with poor drug uptake. Previous studies have shown that treatment with inhibitors of platelet-derived growth factor (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582b9838bb576c469580f8487d85d969
https://doi.org/10.1371/journal.pone.0008149
https://doi.org/10.1371/journal.pone.0008149